Status not kept up to date
Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers
NCT05728606 · Hebei Medical University · Updated 15 Feb 2023
- What is being tested
- Robot-assisted D2 distal gastrectomy
- For
- Gastric Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 70 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 20 Jan 2023, ends 20 June 2024. Registered 15 Feb 2023.
- Results
- None posted yet.
In the researchers' words
To evaluate the safety of robot-assisted radical gastrectomy with D2 lymph node dissection in postoperative complications in patients with neoadjuvant chemotherapy for gastric cancer (cT3-4a, N+, M0).
Sites
- Fourth Affiliated Hospital of Hebei Medical UniversityShijiazhuang, Hebei, China